Major shareholder acquires 105,880 shares of $SSTI

In a recent development, Partners LP Veradace, a significant stakeholder owning 10% of $SSTI shares, made a noteworthy transaction. On 02-18-2026, they acquired 105,880 shares of the company, amounting to a substantial investment of $755,983. This purchase, as per information sourced from the latest SEC filing and analyzed by Quiver Quantitative, led to a 5.6% increase in their ownership of this particular class of $SSTI stock, bringing their total holdings to 2,008,368 shares.

Delving into the insider trading activities within $SSTI over the past six months, it is revealed that there have been a total of seven trades conducted by insiders. Of these transactions, two were acquisitions, while five were divestitures. Partners LP Veradace emerged as a key player, executing two purchases of 114,628 shares valued at $817,831, without any sales reported. On the other hand, Ralph A. Clark, serving as the President and CEO, was noted to have offloaded 16,161 shares for an estimated sum of $190,711. Another notable figure, Nasim Golzadeh, partook in four sales transactions, shedding 5,106 shares for about $44,587 in total.

Shifting gears to hedge fund activity surrounding $SSTI, recent data reveals significant portfolio adjustments by institutional investors. A total of 48 institutions augmented their positions with $SSTI shares, while 54 others reduced their exposure in the most recent quarter. Noteworthy movements include Topline Capital Management, LLC adding 545,666 shares to their holdings, while flagship investor Wasatch Advisors LP divested 345,672 shares. Kopion Asset Management, LLC was observed increasing their stake by 333,170 shares, and Yost Capital Management, LP completely divested its 292,200 shares.

Examining the financials, $SSTI reported revenues of $25.1M in Q3 2025, reflecting a decrease of -4.38% compared to the corresponding period in the preceding year. This financial data can be further explored on Quiver Quantitative’s dedicated $SSTI stock page.

The sentiment among Wall Street analysts towards $SSTI has been largely positive in recent months, with four prominent firms endorsing buy ratings for the stock while no sell ratings were issued. Notable analysts from Citizens, Lake Street, Roth Capital, and Cantor Fitzgerald have expressed favorable outlooks for the stock, with ratings ranging from “Market Outperform” to “Overweight.” Additionally, price targets set by analysts suggest a median value of $15.0 for $SSTI, with individual estimations ranging from $10.0 to $20.0, outlining potential growth prospects for the stock in the foreseeable future.